Insulet Corporation (PODD): Gradient Investments LLC added to its stake +3,191 shares
Gradient Investments LLC added to its stake in Insulet Corporation, per its Q3 2025 13F.
- 59K
- Shares reported · +3,191 vs prior quarter
- 0.30%
- Disclosed portfolio weight
- $18.1M
- Reported value
- Holdings as of
- Sep 30, 2025
- Filed
- Oct 6, 2025
What stands out in this filing
- 55,473 shares in Q2 2025, 58,664 now (+5.8% in share count).
- Reported at $18.1M, 0.30% of the portfolio value in this 13F filing.
- 38 other tracked managers reported the same kind of change for Q3 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 4, 2024CongressDisclosed sale of PODD — reported range $1,001 - $15,000
- Aug 7, 2025InsiderOfficer sold ~$430K of PODD shares in the open market
- Aug 21, 2025InsiderOfficer sold ~$1.42M of PODD shares in the open market
- Sep 8, 2025Insider · 2 peopleInsiders: 2 sales (~$517K)
- Sep 11, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On September 16, 2025, Insulet Corporation (the “Company”) announced that Flavia H. Pease has been appointed to succeed Ana M. Chadwick as Executive Vice President and Chief Financial Officer of the Company.”
- Sep 11, 2025FDARecall: The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying…
What came next
- Oct 21, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“O n October 21, 2025, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Robbie Huffines as a Class II director, effective October 31, 2025.”
- Oct 30, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 12.5%
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Dec 3, 2025FDAFDA device clearance: Omnipod 5 algorithm
- Dec 5, 2025Insider · 6 days before an 8-KDirector purchased ~$300K of PODD shares in the open market
- Dec 11, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 11, 2025, the Committee approved the amendment and restatement of the Company’s Annual Incentive Plan (the “Plan”), effective January 1, 2026, except as otherwise specified therein.”
- Dec 15, 2025Company filing · Form 8-K · Auditor changeChanged its auditor“On December 15, 2025, following careful deliberation and a competitive process, the Audit Committee (the “Committee”) of the Board of Directors of Insulet Corporation (the “Company”) approved the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm, subject to completion of standard client acceptance procedures, and dismissed Grant Thornton LLP (“Grant…”
- Dec 15, 2025InsiderDirector sold ~$543K of PODD shares in the open market
- Jan 29, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Insulet Corporation
For Insulet Corporation, OQRO holds 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PODD page.
How this filing works
Explore the data
Common questions
What does this filing report about Insulet Corporation (PODD) stock?
Gradient Investments LLC added to its stake in Insulet Corporation, per its Q3 2025 13F. Now 59K shares, $18.1M reported value, 0.30% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Sep 30, 2025. Filed: Oct 6, 2025.
What stands out in this filing?
55,473 shares in Q2 2025, 58,664 now (+5.8% in share count). Reported at $18.1M, 0.30% of the portfolio value in this 13F filing. 38 other tracked managers reported the same kind of change for Q3 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Insulet Corporation recently?
For Insulet Corporation, OQRO holds 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the PODD page.
Does this mean PODD stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Insulet Corporation
- SEC Form 13F-HRNov 16, 2026
- SEC Schedule 13GNov 16, 2026
- SEC Schedule 13GNov 13, 2026
- House Clerk periodic transaction reportNov 10, 2026
- House Clerk periodic transaction reportOct 12, 2026
- House Clerk periodic transaction reportSep 10, 2026
Everything OQRO holds on this company is on its PODD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data